notwithstanding the presumptions of the pathogenesis of amyloidosis and the capacity of colchicine to inhibit amyloid synthesis in rats treated with casein , the form in question derived little benefit from the association of colchicine ( 0.5 mg t.i.d . ) and melphalan ( cycles of 4 days every 6 weeks - 0.25 mg/kg/die ) .
C0002726
amyloidosis
C0009262
colchicine